1.Investigation of radon activity concentration and dose assessment in subways of Nanning City, China
Xiufang LU ; Yilong MA ; Rongzheng HUANG ; Ziyue LI ; Jiajie LEI ; Lanying FENG ; Zhangfan CHEN ; Xinchun ZHAO
Chinese Journal of Radiological Health 2026;35(1):67-73
Objective To investigate the radon activity concentrations in subways of Nanning City and assess the average annual effective doses for subway staff and passengers due to radon exposure. Methods Sixty-three stations across the subway lines 2, 3, and 5 were selected as study sites. Radon activity concentrations were measured using the scintillation counting method with scintillation vials. Results The radon activity concentrations in subway lines 2, 3, and 5 were 7.9-24.4, 12.0-26.2, and 12.6-18.2 Bq/m3, respectively. The average radon activity concentrations for these three lines were (17.4 ± 4.6), (19.1 ± 4.1), and (14.6 ± 1.7) Bq/m3, respectively. Statistical analysis using SPSS 26.0 software revealed a significant difference in radon activity concentrations among these stations (P<0.01). Considering the data in previous research, the average radon activity concentration across all stations in the subway lines of Nanning City was determined to be 17.4 Bq/m3. The estimated average annual effective dose due to radon exposure was 0.131 mSv for subway staff and 0.033 mSv for passengers. Conclusion The radon activity concentrations in the subway lines of Nanning City were significantly lower than the national standard limit (400 Bq/m3). The annual effective doses from radon exposure for both subway staff and passengers were below the limits specified in the Basic Standards for Protection Against Ionizing Radiation and for the Safety of Radiation Sources (GB18871—2002). The health impact of radon and its progeny on subway staff and passengers in the subway lines of Nanning City was extremely low and can be considered negligible.
2.Advancements in molecular imaging probes for precision diagnosis and treatment of prostate cancer.
Jiajie FANG ; Ahmad ALHASKAWI ; Yanzhao DONG ; Cheng CHENG ; Zhijie XU ; Junjie TIAN ; Sahar Ahmed ABDALBARY ; Hui LU
Journal of Zhejiang University. Science. B 2025;26(2):124-144
Prostate cancer is the second most common cancer in men, accounting for 14.1% of new cancer cases in 2020. The aggressiveness of prostate cancer is highly variable, depending on its grade and stage at the time of diagnosis. Despite recent advances in prostate cancer treatment, some patients still experience recurrence or even progression after undergoing radical treatment. Accurate initial staging and monitoring for recurrence determine patient management, which in turn affect patient prognosis and survival. Classical imaging has limitations in the diagnosis and treatment of prostate cancer, but the use of novel molecular probes has improved the detection rate, specificity, and accuracy of prostate cancer detection. Molecular probe-based imaging modalities allow the visualization and quantitative measurement of biological processes at the molecular and cellular levels in living systems. An increased understanding of tumor biology of prostate cancer and the discovery of new tumor biomarkers have allowed the exploration of additional molecular probe targets. The development of novel ligands and advances in nano-based delivery technologies have accelerated the research and development of molecular probes. Here, we summarize the use of molecular probes in positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), optical imaging, and ultrasound imaging, and provide a brief overview of important target molecules in prostate cancer.
Humans
;
Male
;
Prostatic Neoplasms/diagnosis*
;
Molecular Probes
;
Molecular Imaging/methods*
;
Magnetic Resonance Imaging
;
Positron-Emission Tomography
;
Tomography, Emission-Computed, Single-Photon
;
Ultrasonography
;
Optical Imaging
;
Biomarkers, Tumor
;
Precision Medicine/methods*
3.The effectiveness and safety of a percutaneous controllable curved plasma radiofrequency ablation device of nucleus pulposus
Hao ZHOU ; Qianyi ZHANG ; Jiajie LU ; Tao WU ; Yituo CHEN ; Qichen ZHANG ; Xilei LI ; Haikang CAI ; Jie TANG
Chinese Journal of Clinical Medicine 2025;32(4):659-664
Objective To verify the safety and effectiveness of a new percutaneous controllable curved plasma radiofrequency instrument for nucleus pulposus ablation. Methods A new percutaneous controllable curved plasma radiofrequency instrument were designed (controllable curved group), and its ablation effect was compared with the currently used straight head non-bendable plasma ablation instrument (non-bendable group) on gross specimens. The ablation instrument was placed through the right intervertebral foramen, and continuous ablation on the same intervertebral disc was conducted for three times. The ablation range and trajectory were recorded, and the temperature changes in the front, back, left, and right of the ablation center during and 15 seconds after ablation were monitored by the inserted temperature probe. Results There were no difference in temperature changes in the front, back, right regions of the ablation center during and 15 seconds after ablation between the two groups. The temperature changes in the left region of the ablation center both during and 15 seconds after 3rd ablation were larger than those in the non-bendable group (P<0.01). Compared with the non-bendable group, the controllable curved group achieved angle control and larger single ablation area (2.282 5 mm² vs 1.135 8 mm², P<0.000 1). Conclusions This new percutaneous controllable curved plasma ablation instrument can achieve angle control and ablation on the side opposite to the puncture site, increase ablation volume, and is safe.
4.Preliminary evaluation of surgical treatment for postpartum diastasis recti
Lu LIU ; Xiaoqiang ZHU ; Nan LIU ; Jiajie LIU ; Rui TANG
Journal of Surgery Concepts & Practice 2024;29(4):329-335
Objective To evaluate the clinical efficacy,safety and the postoperative functional improvement of the surgical treatment for postpartum diastasis recti(PDR).Methods A retrospective study was conducted on the patients with PDR who underwent surgical treatment in Department of Hernia and Abdominal Wall Surgery,Shanghai East Hospital,Tongji University from November 2018 to October 2023.The patients'demography,operation data,postoperative complications,recurrence and functional evaluation before and after surgery were analyzed.Results A total of 39 cases were included.Open surgery was performed in 21 cases,laparoscopic surgery in 17 cases,and hybrid surgery in 1 case.On the basis of linear alba reconstruction(LAR),26 cases were additionally repaired with Sublay mesh,9 with Onlay,and 1 with intraperitoneal onlay mesh(IPOM);the other 3 cases were only performed with LAR.The follow-up ranged 6-45 months,and the completion rate was 92.3%.During the follow-up,no recurrence was observed,and the overall complication rate was 20.5%,including 1 case with delayed wound healing,2 cases with seroma,and 5 cases with skin disorders in paraumbilical and subumbilical area.There were significant changes of European Registry for abdominal wall hernias quality of life(EuraHS QoL)score and Oswestry disability index(ODI)after operation,indicating significant improvement in QoL and lower back pain.The inter-recti distance(IRD)of the patients undergoing laparoscopic surgery was less than that of the patients undergoing open surgery(median 4.0 cm vs.4.5 cm),and the duration of hospital stay of the patients undergoing laparoscopic surgery was shorter than that of open surgery(median 7 days vs.9 days).Conclusions In general,the surgical treatment of PDR is safe and effective,and it can not only correct the separation,but also improve QoL and lower back pain of the patients.Tailored surgical procedures should be selected for patients with different conditions.
5.Construction and Testing of Health LifeStyle Evidence (HLSE)
Chen TIAN ; Yong WANG ; Yilong YAN ; Yafei LIU ; Yao LU ; Mingyao SUN ; Jianing LIU ; Yan MA ; Jinling NING ; Ziying YE ; Qianji CHENG ; Ying LI ; Jiajie HUANG ; Shuihua YANG ; Yiyun WANG ; Bo TONG ; Jiale LU ; Long GE
Medical Journal of Peking Union Medical College Hospital 2024;15(6):1413-1421
Healthy lifestyles and good living habits are effective strategies and important approaches to prevent chronic non-communicable diseases. With the development of evidence-based medicine, the evidence translation system has made some achievements in clinical practice. There is, however, no comprehensive, professional and efficient system for translating lifestyle evidence globally. Therefore, the Health Lifestyle Evidence (HLSE) Group of Lanzhou University constructed the HLSE Evidence Translation System (
6.Method for Developing Patient Decision Aid in China
Yao LU ; Qian ZHANG ; Qianji CHENG ; Jianing LIU ; Mingyao SUN ; Jinling NING ; Jiajie HUANG ; Simeng REN ; Wenzheng ZHANG ; Yajie LIU ; Xiyuan DENG ; Jinhui TIAN ; Jie LIU ; Long GE
Medical Journal of Peking Union Medical College Hospital 2024;15(6):1422-1431
To systematically construct a guideline to provide a methodological guide for researchers to develop patient decision aids. Through a literature review of international methodological guidance for developing patient decision aids, sorting out the similarities and differences in the processes and methods for developing patient decision aids, and combining them with the topic discussion of the working group, the initial guideline was drafted. A total of 13 guidances was included, with the initial version containing 3 phases, 13 steps, and 48 points. We invited 19 multidisciplinary domain experts for forming consensus. The final version of the guideline contains 3 phases, 11 steps, and 24 points. The guideline has great potential to guide the development of patient decision aids in China and is expected to fill the methodological gap in the field. In the future, several rounds of pilot testing of the guideline based on specific decision issues will be conducted, and the guideline will be further revised and improved.
7.Construction and Testing of Health LifeStyle Evidence (HLSE)
Chen TIAN ; Yong WANG ; Yilong YAN ; Yafei LIU ; Yao LU ; Mingyao SUN ; Jianing LIU ; Yan MA ; Jinling NING ; Ziying YE ; Qianji CHENG ; Ying LI ; Jiajie HUANG ; Shuihua YANG ; Yiyun WANG ; Bo TONG ; Jiale LU ; Long GE
Medical Journal of Peking Union Medical College Hospital 2024;15(6):1413-1421
Healthy lifestyles and good living habits are effective strategies and important approaches to prevent chronic non-communicable diseases. With the development of evidence-based medicine, the evidence translation system has made some achievements in clinical practice. There is, however, no comprehensive, professional and efficient system for translating lifestyle evidence globally. Therefore, the Health Lifestyle Evidence (HLSE) Group of Lanzhou University constructed the HLSE Evidence Translation System (
8.Method for Developing Patient Decision Aid in China
Yao LU ; Qian ZHANG ; Qianji CHENG ; Jianing LIU ; Mingyao SUN ; Jinling NING ; Jiajie HUANG ; Simeng REN ; Wenzheng ZHANG ; Yajie LIU ; Xiyuan DENG ; Jinhui TIAN ; Jie LIU ; Long GE
Medical Journal of Peking Union Medical College Hospital 2024;15(6):1422-1431
To systematically construct a guideline to provide a methodological guide for researchers to develop patient decision aids. Through a literature review of international methodological guidance for developing patient decision aids, sorting out the similarities and differences in the processes and methods for developing patient decision aids, and combining them with the topic discussion of the working group, the initial guideline was drafted. A total of 13 guidances was included, with the initial version containing 3 phases, 13 steps, and 48 points. We invited 19 multidisciplinary domain experts for forming consensus. The final version of the guideline contains 3 phases, 11 steps, and 24 points. The guideline has great potential to guide the development of patient decision aids in China and is expected to fill the methodological gap in the field. In the future, several rounds of pilot testing of the guideline based on specific decision issues will be conducted, and the guideline will be further revised and improved.
9.Correlation between serum lipoprotein(a) and early neurological deterioration in patients with branch atherosclerotic disease
Jiajie LU ; Jia'nan YAN ; Pengyu GONG
International Journal of Cerebrovascular Diseases 2024;32(11):821-826
Objective:To investigate the correlation between lipoprotein(a) and early neurological deterioration (END) in patients with branch atherosclerotic disease (BAD).Methods:Patients with BAD admitted to the Affiliated Hospital of Nantong University from January 2024 to September 2024 were included retrospectively. The demographic and baseline clinical data were collected. END was defined as an increase of ≥2 in the National Institutes of Health Stroke Scale (NIHSS) score from baseline within 1 week after onset, including an increase of ≥1 in motor function score. Multivariate logistic regression analysis was used to identify the independent risk factors for END in patients with BAD. Receiver operating characteristic (ROC) curve was used to evaluate the predictive value of lipoprotein(a) for END. Results:A total of 214 patients with BAD were enrolled; including 134 males (62.6%), aged 65.60±11.96 years. The median baseline NIHSS score was 3 (interquartile range, 2-5), the median onset-to-door time was 16 hours (interquartile range, 10-24 hours), and the median onset to blood collection time was 25 hours (interquartile range, 20-38 hours). 141 patients (65.89%) had lenticulostriate arteries infarction, and 73 patients (34.11%) had paramedian pontine arteries infarction. 28 patients (13.08%) received intravenous thrombolysis, and 72 (33.64%) experienced END. Univariate analysis showed that there were significant differences in gender composition, baseline NIHSS score, serum lipoprotein(a), and proportion of patients receiving intravenous thrombolysis between the END group and the non-END group (all P<0.05). Multivariate logistic regression analysis showed that higher lipoprotein(a) (odds ratio [ OR] 1.033, 95% confidence interval [ CI] 1.015-1.052; P<0.001) and intravenous thrombolysis ( OR 2.799, 95% CI 1.109-7.065; P=0.029) were the independent risk factors for END in patients with BAD. ROC curve analysis showed that the area under the curve of lipoprotein(a) for predicting END was 0.621 (95% CI 0.54-0.70). The optimal cutoff value was 23.36 mg/dl. The sensitivity and specificity were 45.8% and 76.8%, respectively. Conclusion:Higher lipoprotein(a) is associated with END in patients with BAD, but its predictive value for END is limited.
10.Clinical efficacy and safety of modified proceedure for prolapse and hemorrhoids combined with partial internal anal sphincterotomy in the treatment of annular mixed hemorrhoids
Yi LI ; Wenzhong LI ; Shiyun LUO ; Xuyuan CHEN ; Lu SHI ; Jiajie HE ; Jiao FENG ; Linpu LI ; Wei HU
Journal of Clinical Surgery 2023;31(11):1049-1052
Objective To explore the clinical efficacy and safety of modified PPH combined with partial internal anal sphincterotomy in the treatment of circular mixed hemorrhoids.Methods Patients with annular mixed hemorrhoids were divided into two groups by a completely randomized controlled method.54 patients in the experimental group were treated with modified PPH combined with partial internal anal sphincterotomy,while 51 patients in the control group were treated with conventional PPH.The postoperative indicators,perioperative and long-term complication rates of the two groups were compared,and the clinical efficacy and safety were observed.Results The operation time in the experimental group was(48.35±4.37)minutes,which was higher than that in the control group(36.42 ±6.21)minutes(P<0.05).The incidence of postoperative anastomotic stenosis in the experimental group was 1.9%,lower than 15.6% in the control group(P<0.05).Anal pain,urinary retention,first defecation time,long-term anal distention,the experimental group was significantly better than the control group,the difference was statistically significant(P<0.05);The hospitalization time in the experimental group(4.8±0.62)days was not significantly different from that in the control group(5.1±0.54)days(P>0.05).The amount of intraoperative bleeding and anastomotic bleeding in the experimental group[(17.28±2.22)ml,3.7%]were not significantly different from those in the control group[(16.75± 2.13)ml,3.9%](P>0.05).Conclusion Compared with conventional PPH,the modified PPH combined with partial internal anal sphincterotomy slightly increases the operation time,but does not increase the risk of anastomotic bleeding,the incidence of rectal fistula,the amount of surgical bleeding,and the length of hospital stay.It can significantly improve postoperative anal pain,urinary retention,long-term distention symptoms,shorten the time of first defecation,ease the difficulty of defecation,and significantly reduce postoperative anastomotic stenosis,The long-term efficacy and safety are good.

Result Analysis
Print
Save
E-mail